In a previous study, LAIR2 was identified as a potential predictor of HDACi resistance in CTCL, as LAIR2 was significantly higher in skin biopsies and blood from patients with HDACi-resistant MF/SS. The gene discussed is LAIR2; the disease is synovial sarcoma.